| Literature DB >> 15765139 |
Stefanie Dimmeler1, Andreas M Zeiher, Michael D Schneider.
Abstract
In humans, the biological limitations to cardiac regenerative growth create both a clinical imperative--to offset cell death in acute ischemic injury and chronic heart failure--and a clinical opportunity; that is, for using cells, genes, and proteins to rescue cardiac muscle cell number or in other ways promote more efficacious cardiac repair. Recent experimental studies and early-phase clinical trials lend credence to the visionary goal of enhancing cardiac repair as an achievable therapeutic target.Entities:
Mesh:
Year: 2005 PMID: 15765139 PMCID: PMC1052009 DOI: 10.1172/JCI24283
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808